Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.
Clinical trial NCT03468790 · COMPLETED
Trial details
- NCT number
- NCT03468790
- Sponsor
- Shanghai Biomabs Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-09
- Primary completion
- 2021-01-12
- Enrollment
- 393
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.